{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T12:10:42Z","timestamp":1773403842268,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,5,5]],"date-time":"2014-05-05T00:00:00Z","timestamp":1399248000000},"content-version":"vor","delay-in-days":1585,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neoplasia"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1593\/neo.09948","type":"journal-article","created":{"date-parts":[[2015,4,23]],"date-time":"2015-04-23T12:58:48Z","timestamp":1429793928000},"page":"1-10","source":"Crossref","is-referenced-by-count":66,"title":["An Orally Available Small-Molecule Inhibitor of c-Met, PF-2341066, Reduces Tumor Burden and Metastasis in a Preclinical Model of Ovarian Cancer Metastasis"],"prefix":"10.1016","volume":"12","author":[{"given":"Marion","family":"Zillhardt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James G.","family":"Christensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ernst","family":"Lengyel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1593\/neo.09948_bib1","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3322\/CA.2007.0010","article-title":"Cancer statistics, 2003","volume":"58","author":"Jemal","year":"2008","journal-title":"CA Cancer J Clin"},{"key":"10.1593\/neo.09948_bib2","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1056\/NEJMra041842","article-title":"Cancer of the ovary","volume":"351","author":"Cannistra","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1593\/neo.09948_bib3","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0025-6196(11)61196-8","article-title":"Current management strategies for ovarian cancer","volume":"82","author":"Aletti","year":"2007","journal-title":"Mayo Clin Proc"},{"key":"10.1593\/neo.09948_bib4","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/nrm1261","article-title":"Met, metastasis, motility and more","volume":"4","author":"Birchmeier","year":"2003","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1593\/neo.09948_bib5","doi-asserted-by":"crossref","first-page":"E161","DOI":"10.1038\/35083116","article-title":"Pathway specificity for Met signalling","volume":"3","author":"Comoglio","year":"2001","journal-title":"Nat Cell Biol"},{"key":"10.1593\/neo.09948_bib6","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1158\/0008-5472.CAN-06-1147","article-title":"c-Met overexpression is a prognostic factor in ovarian cancer and an effective target for inhibition of peritoneal dissemination and invasion","volume":"67","author":"Sawada","year":"2007","journal-title":"Cancer Res"},{"key":"10.1593\/neo.09948_bib7","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/j.1525-1438.2005.00117.x","article-title":"Expression of the c-Met in advanced epithelial ovarian cancer and its prognostic significance","volume":"15","author":"Ayhan","year":"2005","journal-title":"Int J Gynecol Cancer"},{"key":"10.1593\/neo.09948_bib8","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0002-9440(10)65130-9","article-title":"Comparison of c-met expression in ovarian epithelial tumors and normal epithelia of the female reproductive tract by quantitative laser scan microscopy","volume":"155","author":"Huntsman","year":"1999","journal-title":"Am J Pathol"},{"key":"10.1593\/neo.09948_bib9","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1111\/j.1525-1438.2007.01135.x","article-title":"Effect of a c-Met -specific, ATP-competitive small-molecule inhibitor SU11274 on human ovarian carcinoma cell growth, motility, and invasion","volume":"18","author":"Koon","year":"2007","journal-title":"Int J Gynecol Cancer"},{"key":"10.1593\/neo.09948_bib10","first-page":"2045","article-title":"Modulation of c-MET proto-oncogene (HGF receptor) mRNA abundance by cytokines and hormones: evidence for rapid decay of the 8 kb c-MET transcript","volume":"9","author":"Moghul","year":"1994","journal-title":"Oncogene"},{"key":"10.1593\/neo.09948_bib11","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/ijc.2910580507","article-title":"Overexpression of the MET\/HGF receptor in ovarian cancer","volume":"58","author":"Di Renzo","year":"1994","journal-title":"Int J Cancer"},{"key":"10.1593\/neo.09948_bib12","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nrd2530","article-title":"Drug development of MET inhibitors: targeting oncogene addiction and expedience","volume":"7","author":"Comoglio","year":"2008","journal-title":"Nat Rev Drug Discov"},{"key":"10.1593\/neo.09948_bib13","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1593\/neo.09230","article-title":"The plasicity of oncogene addiction: Implications for targeted therapies directed to receptor tyrosine kinases","volume":"11","author":"Vinochani","year":"2009","journal-title":"Neoplasia"},{"key":"10.1593\/neo.09948_bib14","doi-asserted-by":"crossref","first-page":"4360","DOI":"10.1158\/0008-5472.CAN-07-5960","article-title":"MetMAb, the one-armed 5D5 anti-c-Met antibody, inhibits orthotopic pancreatic tumor growth and improves survival","volume":"68","author":"Jin","year":"2008","journal-title":"Cancer Res"},{"key":"10.1593\/neo.09948_bib15","doi-asserted-by":"crossref","first-page":"5387","DOI":"10.1038\/sj.onc.1207691","article-title":"The Met kinase inhibitor SU11274 exhibits a selective inhibition pattern toward different receptor mutated variants","volume":"23","author":"Berthou","year":"2004","journal-title":"Oncogene"},{"key":"10.1593\/neo.09948_bib16","doi-asserted-by":"crossref","first-page":"4885","DOI":"10.1038\/sj.onc.1205622","article-title":"K252a inhibits the oncogenic properties of Met, the HGF receptor","volume":"21","author":"Morotti","year":"2002","journal-title":"Oncogene"},{"key":"10.1593\/neo.09948_bib17","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1073\/pnas.0508776103","article-title":"Amplification of MET may identify a subset of cancers with extreme sensitivity to the selective tyrosine kinase inhibitor PHA-665752","volume":"103","author":"Smolen","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1593\/neo.09948_bib18","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1158\/1535-7163.MCT-07-0365","article-title":"Cytoreductive antitumor activity of PF-2341066, a novel inhibitor of anaplastic lymphoma kinase and c-Met, in experimental models of anaplastic large-cell lymphoma","volume":"6","author":"Christensen","year":"2007","journal-title":"Mol Cancer Ther"},{"key":"10.1593\/neo.09948_bib19","doi-asserted-by":"crossref","first-page":"4408","DOI":"10.1158\/0008-5472.CAN-06-4443","article-title":"An orally available small-molecule inhibitor of c-Met, PF-2341066, exhibits cytoreductive antitumor efficacy through antiproliferative and antiangiogenic mechanisms","volume":"67","author":"Zou","year":"2007","journal-title":"Cancer Res"},{"key":"10.1593\/neo.09948_bib20","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2174\/156652407779940486","article-title":"Tyrosine kinase mutations in human cancer","volume":"7","author":"Lengyel","year":"2007","journal-title":"Curr Mol Med"},{"key":"10.1593\/neo.09948_bib21","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1172\/JCI33775","article-title":"The initial steps of ovarian cancer cell metastasis are mediated by MMP-2 cleavage of vitronectin and fibronectin","volume":"118","author":"Kenny","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1593\/neo.09948_bib22","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1128\/MCB.16.3.1115","article-title":"Enhanced tumorigenicity and invasion-metastasis by hepatocyte growth factor\/scatter factor-met signalling in human cells concomitant with induction of the urokinase proteolysis network","volume":"16","author":"Jeffers","year":"1996","journal-title":"Mol Cell Biol"},{"key":"10.1593\/neo.09948_bib23","first-page":"963","article-title":"Induction of Mr 92,000 type IV collagenase expression in a squamous cell carcinoma cell line by fibroblasts","volume":"55","author":"Lengyel","year":"1995","journal-title":"Cancer Res"},{"key":"10.1593\/neo.09948_bib24","first-page":"3668","article-title":"Comparative properties of five human ovarian adenocarcinoma cell lines","volume":"45","author":"Buick","year":"1985","journal-title":"Cancer Res"},{"key":"10.1593\/neo.09948_bib25","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1200\/JCO.2006.07.9970","article-title":"Early events in the pathogenesis of epithelial ovarian cancer","volume":"26","author":"Landen","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1593\/neo.09948_bib26","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/BF00058063","article-title":"In vitro degradation of extracellular matrix by human ovarian carcinoma cells","volume":"5","author":"Niedbala","year":"1987","journal-title":"Clin Exp Metastasis"},{"key":"10.1593\/neo.09948_bib27","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s10555-006-7886-9","article-title":"Matrix metalloproteinases and tumor metastasis","volume":"25","author":"Deryugina","year":"2009","journal-title":"Cancer Metastasis Rev"},{"key":"10.1593\/neo.09948_bib28","first-page":"2396","article-title":"Increased expression of matrix metalloproteinases (MMP)-2, MMP-9, and the urokinase-type plasminogen activator is associated with progression from benign to advanced ovarian cancer","volume":"7","author":"Schmalfeldt","year":"2001","journal-title":"Clin Cancer Res"},{"key":"10.1593\/neo.09948_bib29","doi-asserted-by":"crossref","first-page":"13868","DOI":"10.1073\/pnas.94.25.13868","article-title":"A point mutation in the MET oncogene abrogates metastasis without affecting transformation","volume":"94","author":"Giordano","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1593\/neo.09948_bib30","doi-asserted-by":"crossref","first-page":"e1279","DOI":"10.1371\/journal.pone.0001279","article-title":"Mutation analysis of BRAF, MEK1 and MEK2 in 15 ovarian cancer cell lines: Implications for therapy","volume":"2","author":"Estep","year":"2007","journal-title":"PLoS ONE"},{"key":"10.1593\/neo.09948_bib31","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/384173a0","article-title":"Interaction between Gab1 and the c-Met receptor tyrosine kinase is responsible for epithelial morphogenesis","volume":"384","author":"Weidner","year":"1996","journal-title":"Nature"},{"key":"10.1593\/neo.09948_bib32","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0092-8674(94)90318-2","article-title":"A multifunctional docking site mediates signaling and transformation by the hepatocyte growth factor\/scatter factor receptor family","volume":"77","author":"Ponzetto","year":"1994","journal-title":"Cell"},{"key":"10.1593\/neo.09948_bib33","doi-asserted-by":"crossref","first-page":"14379","DOI":"10.1073\/pnas.95.24.14379","article-title":"Uncoupling signal transducers from oncogenic MET mutants abrogates cell transformation and inhibits invasive growth","volume":"95","author":"Bardelli","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1593\/neo.09948_bib34","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1038\/sj.gt.3301553","article-title":"Expression of HGF\/NK4 in ovarian cancer cells suppresses intraperitoneal dissemination and extends host survival","volume":"8","author":"Saga","year":"2001","journal-title":"Gene Ther"},{"key":"10.1593\/neo.09948_bib35","doi-asserted-by":"crossref","first-page":"3529","DOI":"10.1158\/0008-5472.CAN-06-4416","article-title":"A selective small molecule inhibitor of c-Met, PHA665752, inhibits tumorigenicity and angiogenesis in mouse lung cancer xenografts","volume":"67","author":"Puri","year":"2007","journal-title":"Cancer Res"},{"key":"10.1593\/neo.09948_bib36","doi-asserted-by":"crossref","first-page":"3691","DOI":"10.1200\/JCO.2002.12.033","article-title":"Molecular Biology of Anaplastic Lymphoma Kinase-Positive Anaplastic Large-Cell Lymphoma","volume":"20","author":"Kutok","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1593\/neo.09948_bib37","doi-asserted-by":"crossref","first-page":"5623","DOI":"10.1038\/sj.onc.1204594","article-title":"Translocations involving anaplastic lymphoma kinase (ALK)","volume":"20","author":"Duyster","year":"2001","journal-title":"Oncogene"},{"key":"10.1593\/neo.09948_bib38","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrc2291","article-title":"The anaplastic lymphoma kinase in the pathogenesis of cancer","volume":"8","author":"Chiarle","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"10.1593\/neo.09948_bib39","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1007\/s00018-004-4275-9","article-title":"The emerging normal and disease-related roles of analplastic lymphoma kinase","volume":"61","author":"Pulford","year":"2004","journal-title":"Cell Mol Life Sci"},{"key":"10.1593\/neo.09948_bib40","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.4161\/cc.6.13.4433","article-title":"ALK is a novel dependence receptor: potential implications in development and cancer","volume":"6","author":"Allouche","year":"2007","journal-title":"Cell Cycle"}],"container-title":["Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147655861080079X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147655861080079X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,23]],"date-time":"2018-09-23T07:50:50Z","timestamp":1537689050000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S147655861080079X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["S147655861080079X"],"URL":"https:\/\/doi.org\/10.1593\/neo.09948","relation":{},"ISSN":["1476-5586"],"issn-type":[{"value":"1476-5586","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]}}}